Long-term treatment with citicoline may improve poststroke vascular cognitive impairment

Cerebrovascular Diseases

Volumn 35, Issue 2, 2013, Pages 146-154

  Alvarez Sabín, Jose ^a   Ortega, Gemma ^a   Jacas, Carlos ^b   Santamarina, Estevo ^a   Maisterra, Olga ^a   Ribo, Marc ^a   Molina, Carlos ^a   Quintana, Manuel ^a   Román, Gustavo C ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Attention; Citicoline; Cognition; Executive function; Poststroke dementia; Stroke; Vascular dementia

Indexed keywords

CITICOLINE;

AGE DISTRIBUTION; AGED; ARTICLE; ATTENTION; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DEPTH PERCEPTION; DISEASE CLASSIFICATION; DRUG EFFICACY; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; MOTOR ACTIVITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROPSYCHOLOGY; OPEN STUDY; PARALLEL DESIGN; POSTSTROKE VASCULAR COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RANKIN SCALE; RISK ASSESSMENT; SEX DIFFERENCE; TIME PERCEPTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADULT; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; COMPARATIVE STUDY; DRUG SAFETY; LACUNAR STROKE; LONG TERM CARE; MOTOR CONTROL; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COGNITION; COGNITION DISORDERS; CYTIDINE DIPHOSPHATE CHOLINE; DEMENTIA, VASCULAR; DISABILITY EVALUATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; SPAIN; STROKE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873605697     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000346602     Document Type: Article

References (42)

1. Lees R, Fearon P, Harrison JK, Broomfield NM, Quinn TJ: Cognitive and mood assessment in stroke research: focused review of contemporary studies. Stroke 2012; 43:1678-1680.
2. Jaillard A, Grand S, François Le Bas J, Hommel M: Predicting cognitive disfunctioning in nondemented patients early after stroke. Cerebrovasc Dis 2010; 29:415-423.
3. Tham W, Auchus AP, Thong M, Chang HM, Wong MC, Chen CP: Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci 2002; 203-204: 49-52.
4. Madureira S, Guerreiro M, Ferro JM: Dementia and cognitive impairment three months after stroke. Eur J Neurol 2001; 8:621-627.
5. Rasquin SMC, Verhey FRJ, van Oostenbrugge RJ, Lousberg R, Lodder J: Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry 2004; 75:1562-1567.
6. Wentzel C, Rockwood K, MacKnight C, et al: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 57:714-716.
7. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C, Medical Research Council Cognitive Function and Ageing Study: Age, neuropathology and dementia. N Engl J Med 2009; 360:2302-2309.
8. Fotuhi M, Hachinski V, Whitehouse PJ: Changing perspectives regarding late-life dementia. Nat Rev Neurol 2009; 5:649-658.
9. Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MMB: Prestroke cognitive performance, incident stroke, and risk of dementia. The Rotterdam study. Stroke 2008; 39:36-41.
10. Gutierrez M, Diez Tejedor E, Alonso de Leciñana M, Fuentes B, Carceller F, Roda JM: Thrombolysis and neuroprotection in cerebral ischemia. Cerebrovasc Dis 2006; 21(suppl 2):118-126.
11. Secades JJ, Lorenzo JL: Citicoline: Pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006; 28:B1-B56.
12. Hurtado O, Lizasoain I, Moro MA: Neuroprotection and recovery. Recent data at the bench on citicoline. Stroke 2011; 42(suppl 1): S33-S35.
13. Davalos A, Castillo J, Alvarez-Sabin J, Secades JJ, Mercadal J, López S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R: Oral citi-coline in acute ischemic stroke. Stroke 2002; 33:2850-2857.
14. Davalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Se-cades JJ, International Citicoline Trial on Acute Stroke (ICTUS) Trial Investigators: Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multi-centre, placebo-controlled study (ICTUS trial). Lancet 2012; 380:349-357.
15. Cho HJ, Kim YJ: Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4, 191 cases. Methods Find Exp Clin Pharmacol 2009; 3:171-176.
16. Fioravanti M, Yanagi M: Cytidinediphos-phocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Co-chrane Database System Rev 2005:CD000269.
17. Lezak M, Howieson DB, Loring DW: Neuro-psychological Assessment, ed 4. New York, Oxford University Press, 2004.
18. Mitrushina M, Boone KL, D'Elia L: Handbook of Normative Data for Neuropsycholog-ical Assesment, ed 2. New York, Oxford University Press, 2005.
19. Strauss E, Shermann EMS, Spreen O: A Compendium of Neuropsychological Tests, ed 3. New York, Oxford University Press, 2006.
20. Savva GM, Stephan BC, Alzheimer's Society Vascular Dementia Systematic Review Group: Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010; 41:e41-e46.
21. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ: Effect of infarcts on dementia in the Baltimore Longitudinal Study of Aging. Ann Neurol 2008; 64: 168-176.
22. Barker-Collo S, Feigin VL, Parag V, Lawes CM, Senior H: Auckland Stroke Outcomes Study. 2. Cognition and functional outcomes 5 years poststroke. Neurology 2010; 75:1608-1616.
23. Patel MD, Coshall C, Rudd AG, Wolfe CD: Cognitive impairment after stroke: clinical determinants and its associations with longterm stroke outcomes. J Am Geriatr Soc 2002; 50:700-706.
24. Saczynski JS, Sigurdsson S, Jonsdottir MK, et al: Cerebral infarcts and cognitive performance. Importance of location and number of infarcts. Stroke 2009; 40:677-682.
25. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348:1215-1222.
26. Cukierman T, Gerstein HC, Williamson JD: Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005; 48:2460-2469.
27. Rasquin SM, Lodder J, Ponds RW, Winkens I, Jolles J, Verhey FR: Cognitive functioning after stroke. A one-year follow-up study. Dementia Geriatr Cognitive Dis 2004; 18:138-144.
28. Rohling ML, Faust ME, Beverly B, Demakis G: Effectiveness of cognitive rehabilitation following acquired brain injury: a meta-ana-lytic re-examination of Cicerone et al.'s (2000, 2005) systematic reviews. Neuropsychology 2009; 23:20-39.
29. Cicerone KD, Dahlberg C, Kalmar K, Langenbahn DM, Malec JF, Bergquist TF, Felicetti T, Giacino JT, Harely JP, Harrington DE, Herzog J, Kneipp S, Laatsch L, Morse PA: Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehabil 2000; 12:1596-1615.
30. Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, Kalmar K, Giacino JT, Harley JP, Laatsch L, Morse PA, Catanese J: Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil 2005; 86:1681-1692.
31. Wilson BA: The effectiveness rehabilitation of memory-related disabilities; in Halligan PW, Wade DT (eds): Effectiveness of Rehabilitation for Cognitive Deficits. New York, Oxford, 2005, pp 143-151.
32. Adibhatla RM, Hatcher JF, Dempsey RJ: Effect of citicoline on phospholipids and gluta-thione levels in transient cerebral ischemia. Stroke 2001; 32:2376-2381.
33. Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tome P, Leza JC, et al: Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005; 18:336-345.
34. Tovarelli G, DeMedio G, Dorman R, Piccinin G, Horrocks L, Porcellati G: Effects of cytidine diphosphate choline (CDP-choline) on ischemia-induced alteration of brain lipid in the gerbil. Neurochem Res 1981; 6:821-833.
35. Krupinski J, Ferrer I, Barrachina M, Secades JJ, Mercadal J, Lozano R: CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology 2002; 42: 846-854.
36. Sahin S, Alkan T, Temel SG, Tureyen K, Tolu-nay S, Korfali E: Effects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in rats. J Clin Neurosci 2010; 17: 227-231.
37. Hurtado O, Cárdenas A, Pradillo JM, Morales JR, Ortego F, Sobrino T, Castillo J, Moro MA, Lizasoain I: A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis 2007; 26:105-111.
38. Sun D, Bullock MR, McGinn MJ, Zhou Z, Altememi N, Hagood S, Hamm R, Colello RJ: Basic fibroblast growth factor-enhanced neu-rogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp Neurol 2009; 216:56-65.
39. Diederich K, Frauenknecht K, Minnerup J, Schneider BK, Schmidt A, Altach E, Eggert V, Sommer CJ, Schäbitz WR: Citicoline enhances neuroregenerative process after experimental stroke in rats. Stroke 2012; 43:1931-1940.
40. Sobrino T, Hurtado O, Moro MA, Rodriguez-Yáñez M, Castellanos M, Brea D, et al: The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007; 38:2759-2764.
41. Sobrino T, Arias S, Rodriguez-Osorio X, Brea D, Rodriguez-Gonzalez R, Ramos P, Castillo J: CDP-choline treatment improves functional recovery by an increment of circulating endothelial progenitor cells in human acute ischemic stroke. J Neurochemistry 2007; 101(suppl 1):43.
42. Baune BT: The puzzle of predicting the impact of brain infarcts on cognitive impairment in the aging brain. Stroke 2009; 40:667-669.